This is public info Catalyst Pharmaceuticals In
Post# of 148331
Catalyst Pharmaceuticals Inc
Catalyst Pharma sues FDA over approval of cheaper rival drug. (Reuters) - Catalyst Pharmaceuticals Inc, which has come under fire for the high price tag on its rare disease drug, on Wednesday sued the U.S. Food and Drug Administration to challenge the recent approval of a lower-cost rival drug.Jun 12, 2019